Jeuveau: The Newer Wrinkle Relaxer That Competes with Botox

What Is Jeuveau?

Jeuveau (pronounced “joo-VOH”) is the brand name for prabotulinumtoxinA, a type of botulinum toxin type A made by Evolus Inc. It received FDA approval in February 2019, making it the fifth FDA-approved botulinum toxin for cosmetic use in the United States. The others are Botox, Dysport, Xeomin, and Daxxify.

All botulinum toxins work by temporarily blocking nerve signals to specific facial muscles. This causes those muscles to relax, softening the wrinkles that form when you move your face — such as the vertical lines between the eyebrows (called glabellar lines or “11s”), forehead lines, and crow’s feet.

How It Works

Jeuveau works exactly the same way as Botox and Xeomin. Once injected into a muscle, it blocks the release of acetylcholine — the chemical signal that tells a muscle to contract. Without that signal, the targeted muscle stays relaxed and the skin above it smooths out.

The effect is temporary. Over 12–16 weeks, the nerve endings form new connections, the muscle regains its function, and wrinkles gradually return. This is why neurotoxin treatments need to be repeated to maintain results — typically every 3–4 months.

What to Expect During Treatment

A Jeuveau appointment is quick and straightforward:

• Your provider will assess your facial muscles and mark the injection sites.
• The skin is cleaned. A topical numbing cream may be applied, though most patients find the injections minimally uncomfortable.
• Small amounts (measured in units) of Jeuveau are injected with a very fine needle into the target muscles. For frown lines, the FDA-approved dose is 20 units — the same as Botox.
• The appointment itself takes 10–15 minutes.
• You can return to work or daily activities immediately afterward.

Results and Recovery

Here is what to expect after your Jeuveau treatment:

• Days 3–7: You will start to notice the muscles relaxing and wrinkles softening. This is a mid-range onset — faster than Botox (which typically takes 5–7 days) but not as fast as Dysport (2–3 days).
• Days 10–14: Full effect is reached. This is the best time to assess results and determine if a touch-up is needed for any asymmetry.
• Months 3–4: Results gradually wear off as nerve activity returns. Most patients schedule their next appointment at 3–4 month intervals.

There is no downtime. Some patients notice small bumps or redness at the injection sites that resolve within 30–60 minutes. Avoid rubbing the treated area, lying face-down, or exercising vigorously for 4 hours after treatment.

Benefits and Risks

Benefits:

• Clinically equivalent to Botox — proven in FDA Phase III trials (70–75% of patients achieved significant improvement in glabellar lines at day 30)
• Competitive pricing, often $8–12 per unit versus $10–15 per unit for Botox
• 1:1 unit conversion with Botox and Xeomin — no complicated dose adjustments if switching
• Results in 3–7 days — slightly faster onset than Botox for many patients
• No significant downtime

Risks (same as all botulinum toxins):

• Temporary bruising at injection sites (5–10% of patients)
• Temporary headache after treatment (1–7%)
• Mild swelling or redness (5–10%)
• Eyebrow or eyelid drooping (ptosis) if product migrates — less than 1% with proper technique
• Asymmetry, usually minor and correctable with a small touch-up
• All side effects resolve naturally within 3–4 months as the toxin wears off

Jeuveau has no unique safety signals compared to other botulinum toxins. It should not be used during pregnancy or breastfeeding, or in patients with certain neuromuscular disorders.

Who Is a Good Candidate?

Jeuveau may be right for you if:

• You have dynamic facial wrinkles — lines that appear or deepen when you move your face
• You are interested in a cost-effective alternative to Botox with equivalent results
• You have previously responded well to Botox or Xeomin and want to switch to save money
• You are in good general health and not pregnant or breastfeeding
• You have realistic expectations — wrinkles soften but do not disappear completely, and results are temporary

If you are currently using Dysport, note that the unit conversion is different. Three to four units of Dysport equal roughly one unit of Jeuveau, so your provider will need to adjust your dose carefully when switching.

How Does Jeuveau Compare to Botox?

Jeuveau and Botox are clinically equivalent. FDA trials compared them head-to-head and found no meaningful difference in results or safety. Here is a quick comparison of all neurotoxins currently available:

• Botox: 20+ years of data, highest brand recognition, $10–15/unit, onset 5–7 days, lasts 12–16 weeks
• Dysport: Fast onset (2–3 days), spreads more widely (useful in some areas), $5–8/unit, requires higher unit doses
• Xeomin: “Naked” formulation without complexing proteins, possibly lower allergy risk, similar price and efficacy to Botox
• Daxxify: Longest duration (approximately 6 months), higher cost per treatment
• Jeuveau: Equivalent efficacy to Botox, competitive pricing, mid-range onset (3–7 days)

When to See a Dermatologist

If you are considering Jeuveau or any botulinum toxin, schedule a consultation with a board-certified dermatologist experienced in facial injectables. They will evaluate your facial anatomy, determine appropriate dosing, and perform injections with precision. Seek evaluation right away if you experience:

• Difficulty swallowing, speaking, or breathing after treatment (very rare)
• Significant drooping of an eyelid or eyebrow that concerns you
• Vision changes
• Marked asymmetry that does not improve after 2 weeks

Frequently Asked Questions

Q: Is Jeuveau as effective as Botox?
A: Yes. FDA clinical trials showed Jeuveau is non-inferior (meaning equally effective) to Botox at equivalent doses. There is no evidence that either is superior — the difference is in price and marketing, not clinical outcomes.

Q: Can I switch from Botox to Jeuveau?
A: Yes, and the conversion is simple — it is 1:1 with Botox and Xeomin. If you received 20 units of Botox for your glabella, you would use 20 units of Jeuveau. Most patients notice no difference in results when switching.

Q: Why is Jeuveau less expensive than Botox?
A: Jeuveau entered the market after Botox and positioned itself as a price-competitive option to gain market share. The lower price reflects business strategy, not a difference in quality or efficacy.

Q: Can Jeuveau treat excessive sweating or migraines?
A: Botox has specific FDA approval for hyperhidrosis (excessive sweating) and chronic migraine. Jeuveau can be used off-label (meaning outside its FDA-approved indication) for these conditions, but insurance coverage is less consistent. Check with your provider and insurer before scheduling.